ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag art genomics innovation trump

Illustration showing a puzzle piece of DNA being removed
Large Scientific Collaborations Aim to Complete Human Genome
Brianna Chrisman and Jordan Eizenga | Sep 1, 2022 | 10+ min read
Thirty years out from the start of the Human Genome Project, researchers have finally finished sequencing the full 3 billion bases of a person’s genetic code. But even a complete reference genome has its shortcomings.
Top 10 Innovations 2016
The Scientist | Dec 1, 2016 | 10+ min read
This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.
Genome Investigator Craig Venter Reflects On Turbulent Past And Future Ambitions
Karen Young Kreeger | Jul 23, 1995 | 8 min read
And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo
One Step Beyond: Going Beyond Genomics With Proteomics And Two-Dimensional Gel Technology
Laura Defrancesco | Jan 3, 1999 | 10+ min read
Proteomes and 2D Gel Apparatus Providers Big science has moved on to proteins. With the new brand of science termed proteomics--named by the Australians Marc Wilkins and Keith Williams to mean the "set of PROTEins encoded by the genOME"--the push is on around the globe to produce a complete description of a cell/tissue/organism in terms of the proteins produced. The challenge is all the greater because the expressed protein pattern changes with time and environment--responding to developmenta
A Living Legacy
Megan Scudellari | Jan 13, 2010 | 10 min read
A Living Legacy At the birthplace of stem cell research, the next generation of scientists continues to advance the field. By Megan Scudellari In Toronto’s downtown Discovery District, world-class stem cell researchers populate the buildings like athletes at the Olympics. On University Avenue, Andras Nagy, a renowned innovator in induced pluripotent stem (iPS) cells, works at the Samuel Lunenfeld Research Institute, housed within the towering Mount Sin
Fishing In A Molecular Sea
Alison Paladichuk | Jan 17, 1999 | 10+ min read
Date: January 18, 1999Labeling Kit Companies Labeling Kit Companies: Details In situ spatial localization of mRNA expressed only after ethylene treatment (left) compared to air grown seedlings used as a negative control (right). The RNA probe to the EIA0305 gene was labeled with fluorescein (NEL633) and visualized with NBT (Image courtesy of New England Nuclear) Remember the days when fishing for a sequence in the E. coli genome seemed like an overwhelming task? Somewhere along the way, it see
An Ocean of Viruses
Joshua S. Weitz and Steven W. Wilhelm | Jul 1, 2013 | 10+ min read
Viruses abound in the world’s oceans, yet researchers are only beginning to understand how they affect life and chemistry from the water’s surface to the sea floor.
Proteomics Power to the People!
John Yates(jyates@scripps.edu) | Jan 30, 2005 | 5 min read
In the postgenomic era, there are the haves and the have-nots.
Squeeze More from Your Samples
Aileen Constans(aconstans@the-scientist.com) | Mar 27, 2005 | 6 min read
In the mid-1990s, toxicologist Raymond Biagini was looking for a faster way to evaluate pest-control workers for exposure to pesticides.
Human Clinical Trials Begin For Cervical Cancer Vaccines
Steve Bunk | Oct 26, 1997 | 6 min read
Efforts are under way to develop a vaccine against one of the world's deadliest illnesses, cervical cancer. Along with a number of university research laboratories, at least a half-dozen biotechnology and pharmaceutical companies are beginning clinical trials or are in preclinical development of such drugs. Efficacy in humans remains to be firmly established, but if the vaccines progress to later-phase trials, challenging jobs for immunologists, microbiologists, and biochemists will multiply. "

Run a Search

ADVERTISEMENT